Leeds
Leeds ECMC draws on the scientific framework from four Yorkshire universities (Leeds, Bradford, Hull and York) to provide infrastructure for experimental cancer medicine studies in early clinical trials and clinical pharmacology, developmental therapeutics, and molecular pathology and biomarkers. The Centre has wide experience of first-in-man and proof-of-principle early clinical trials of small molecules and biotherapies, both as single agents and in combination.
Clinical Focus Area
- Medical oncology
- Radiotherapy
- Surgical Oncology
- Pathology
Scientific Focus Area
- Clinical pharmacokinetics and metabolism
- Sample collection/processing
- Biological therapies
- Molecular pathology
- Early clinical trials
- Imaging (PET and MRI)
- Surgical robotics
Disease Focus Area
| Basic Research | Brain | Breast | Colorectal |
| Kidney | Liver |
Goals
Skills
Leeds ECMC principal investigators and staff have a diverse range of skills and expertise.
Facilities
Leeds ECMC has access to a range of research facilities that are utilised in studies.
Increase text
Decrease text
Print this page